in a prospective randomized trial , febrile , granulocytopenic patients received either piperacillin sodium plus amikacin sulfate or carbenicillin disodium plus amikacin as initial empiric antimicrobial therapy .
C0002501
amikacin sulfate
C0002499
amikacin